InvestorsObserver
×
News Home

Is it Time to Dump NovaBay Pharmaceuticals Inc (NBY) Stock After it Has Risen 38.33% in a Week?

Monday, September 11, 2023 09:58 AM | InvestorsObserver Analysts

Mentioned in this article

Is it Time to Dump NovaBay Pharmaceuticals Inc (NBY) Stock After it Has Risen 38.33% in a Week?

Overall market sentiment has been high on NovaBay Pharmaceuticals Inc (NBY) stock lately. NBY receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

Sentiment Score - ,bullish
NovaBay Pharmaceuticals Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on NBY!

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down. InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend. Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With NBY Stock Today?

NovaBay Pharmaceuticals Inc (NBY) stock is trading at $0.83 as of 9:58 AM on Monday, Sep 11, a gain of $0.21, or 34.39% from the previous closing price of $0.62. Volume today is elevated. So far 30,943,771 shares have traded compared to average volume of 155,156 shares. The stock has traded between $0.82 and $1.28 so far today. To see InvestorsObserver's Sentiment Score for NovaBay Pharmaceuticals Inc click here.

More About NovaBay Pharmaceuticals Inc

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare and skincare products. Its leading product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is proven in laboratory testing to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available direct to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. Click Here to get the full Stock Report for NovaBay Pharmaceuticals Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App